AstraZeneca’s Soriot Warns US Against Trade Tariffs on Drugs (1)

AstraZeneca Plc’s Chief Executive Officer Pascal Soriot warned that trade tariffs are not the best way to manage pharmaceuticals and that drugmakers are calling for no additional US levies on medicines.

“We actually believe that a better incentive to attract investment in manufacturing and in R&D is to have a great tax policy that incentivizes companies to invest in the country,” Soriot said on Bloomberg TV on Tuesday.

AstraZeneca said any impact of levies on the company would be short-lived given its manufacturing presence in the US. Still, Soriot said the industry is lobbying the Trump administration not to ...